Impact of Community Pharmacist-Involved Collaborative Care Model for the Management of Type 2 Diabetes Mellitus
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 2, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 2, 2021Completed
Condition(s):Depression; Generalized Anxiety Disorder; Panic DisorderLast Updated:September 25, 2014Completed
Condition(s):Alcohol Use DisorderLast Updated:September 12, 2019Completed
Condition(s):Severe Orthopedic TraumaLast Updated:April 18, 2017Completed
Condition(s):Heart Failure, Systolic; Depression; Cardiovascular DiseaseLast Updated:August 5, 2020Completed
Condition(s):Substance Use DisordersLast Updated:April 27, 2017Completed
Condition(s):Concussion, Brain; TBI; Depression; AnxietyLast Updated:April 8, 2021Completed
Condition(s):Other CancerLast Updated:April 7, 2022Completed
Condition(s):Bipolar Disorder; Schizophrenia; Major Depressive Disorder; Schizoaffective Disorder; Cardiovascular Disease RiskLast Updated:January 22, 2016Completed
Condition(s):Diabetes Mellitus, Type 2; DepressionLast Updated:November 15, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.